Abstract:
A series of 2-methyl-5-nitrobenzenesulfono-hydrazides were prepared and evaluated as inhibitors of PI3K. An isoquinoline derivative shows good selectivity for the p110a isoform over p110b and p110d, and also demonstrates good in vitro activity in a cell proliferation assay. Molecular modelling provides a rationalisation for the observed SAR.